NCT00001295

Brief Summary

This protocol is to provide continuing medical/surgical/radio-therapeutic care, treatment and follow-up for NCI patients not currently entered on an active research protocol. No investigational treatments will be administered on this protocol.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,145

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 1992

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 29, 1992

Completed
7.8 years until next milestone

First Submitted

Initial submission to the registry

November 3, 1999

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 4, 1999

Completed
16.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 23, 2016

Completed
Last Updated

December 17, 2019

Status Verified

August 23, 2016

First QC Date

November 3, 1999

Last Update Submit

December 14, 2019

Conditions

CancerHIV

Keywords

Follow-UpTreatment

Outcome Measures

Primary Outcomes (1)

  • To provide continuing treatment and medical follow-up for CCR subjects who have completed their treatment and participation on a research protocol and who are not currently entered on or eligible for an active research protocol.

    Open-ended

Eligibility Criteria

AgeUp to 99 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects of any age who have been previously enrolled and treated on an approved CCR research treatment protocol.
  • It is in the best interests of the subject and the CCR for the subject to continue to receive treatment and follow-up at the NIH.
  • The subject or guardian signs the informed consent and agrees to the proposed treatment regimen.

You may not qualify if:

  • Subjects who have not been previously treated on a CCR research treatment protocol.
  • Subjects who are receiving an investigational therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, Maryland, 20892, United States

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Caryn Steakley, R.N.

    National Cancer Institute (NCI)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 3, 1999

First Posted

November 4, 1999

Study Start

January 29, 1992

Study Completion

August 23, 2016

Last Updated

December 17, 2019

Record last verified: 2016-08-23

Locations

US(1)